REN Shuang, ZHU Jing-sheng, XU Ying-ying, ZHI Ji-xin, WU Wei-dong.
Effect of Swimming Exercise on Orexin-1 Receptor in Liver Tissue of High-fat Diet-Induced Obesity-resistant Rats[J]. Acta Nutrimenta Sinica. 2024, 46(6): 622-624
中图分类号：
R151.4+5
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Han Y, Yuan K, Zheng Y, et al. Orexin receptor antagonists as emerging treatments for psychiatric disorders[J]. Neurosci Bull, 2020, 36: 432–448. [2] Roch C, Bergamini G, Steiner MA, et al. Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia[J]. Psychopharmacology (Berl), 2021, 238: 2693–2708. [3] De Boer P, Drevets WC, Rofael H, et al. A randomized phase 2 study to evaluate the orexin-2 receptor antagonist selt orexant in individuals with insomnia without psychiatric comorbidity[J]. J Psychopharmacol, 2018, 32: 668–677. [4] 赵琳, 丁敏, 贾鲲鹏,等. 腹腔注射2-DG对大鼠下丘脑orexin-A神经元表达的影响[J]. 中国应用生理学杂志. 2017, 33: 500–502. [5] Jacobson LH, Chen S, Mir S, et al. Orexin OX2 receptor antagonists as sleep aids[J]. Current Top Behav Neurosci, 2017, 33: 105–136. [6] Yukitake H, Fujimoto T, Ishikawa T, et al. TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice[J]. Pharmacol Biochem Behav. 2019, 187: 172–194. [7] Summers CH, Yaeger JDW, Staton CD, et al. Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: potential for therapy[J]. Brain Res. 2020, 3: 146–185. [8] Skrzypski M, Le TT, Kaczmarek P, et al. Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes[J]. Diabetologia. 2011, 54: 1841–1852
